Simplified dosing of gentamicin for treatment of sepsis in bangladeshi neonates

Journal of Health, Population and Nutrition

Volumn 27, Issue 5, 2009, Pages 640-645

  Hossain, Monir M ^a   Chowdhury, Nazma A ^a   Shirin, Mahfuza ^a   Saha, Samir K ^a   Miller Bell, Mary ^b   Edwards, David ^c   Aranda, Jacob ^c   Coffey, Patricia ^d   Darmstadt, Gary L ^e  

^a DHAKA SHISHU HOSPITAL   (Bangladesh)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d PATH   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Aminoglycoside; Antibiotics; Bangladesh; Gentamicin; Infection; Newborns; Observational studies; Pharmacokinetics; Prospective studies; Sepsis

Indexed keywords

ANTIINFECTIVE AGENT; GENTAMICIN;

ARTICLE; BANGLADESH; BLOOD; BODY WEIGHT; CLINICAL PROTOCOL; CLINICAL TRIAL; DEVELOPING COUNTRY; DRUG ADMINISTRATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEWBORN; NEWBORN DISEASE; OBSERVATION; SEPSIS;

ANTI-BACTERIAL AGENTS; BANGLADESH; BODY WEIGHT; CLINICAL PROTOCOLS; DEVELOPING COUNTRIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENTAMICINS; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFUSIONS, INTRAVENOUS; MALE; OBSERVATION; SEPSIS;

EID: 77957265731     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: 10.3329/jhpn.v27i5.3640     Document Type: Article

References (29)

1. Lawn JE, Cousens S, Zupan J. Four million neonatal deaths: When? Where? Why? Lancet 2005;365:891-900.
2. Stoll BJ. The global impact of neonatal infection. Clin Perinatol 1997;24:1-21.
3. World Health Organization. Postpartum care of the mother and the newborn: a practical guide. Geneva: World Health Organization, 1998. 81 p. (WHO/RHT/ MSM/98.3).
4. Darmstadt GL, Black RE, Santosham M. Research priorities and postpartum care strategies for the prevention and optimal management of neonatal infections in less developed countries. Pediatr Infect Dis J 2000;19:739-50.
5. Ahmed S, Sobhan F, Islam A, Barkat-e-Khuda. Neonatal morbidity and care-seeking behaviour in rural Bangladesh. J Trop Pediatr 2001;47:98-105.
6. Bang AT, Bang RA, Baitule S, Deshmukh M, Reddy MH. Burden of morbidities and the unmet needs for health care in rural neonates-a prospective study in Gadchiroli, India. Indian Pediatr 2001;38:952-65.
7. Baqui AH, El-Arifeen S, Darmstadt GL, Ahmed S, Williams EK, Seraji HR et al. Effect of community-based newborn-care intervention package implemented through two service-delivery strategies in Sylhet district, Bangladesh: a cluster-randomised controlled trial. Lancet 2008;371:1936-44.
8. Darmstadt GL, Baqui AH, Choi Y, Bari S, Rahman SM, Mannan I et al. Validation of community health workers' assessment of neonatal illness in rural Bangladesh. Bull World Health Organ 2009;87:12-9.
9. Hayani KC, Hatzopoulos FK, Frank AL, Thummala MR, Hantsch MJ, Schatz BM et al. Pharmacokinetics of once-daily dosing of gentamicin in neonates. J Pediatr 1997;131:76-80.
10. Thomson AH, Kokwaro GO, Muchohi SN, English M, Mohammed S, Edwards G. Population pharmacokinetics of intramuscular gentamicin administered to young infants with suspected severe sepsis in Kenya. Br J Clin Pharmacol 2003;56:25-31.
11. English M, Mohammed S, Ross A, Ndirangu S, Kokwaro G, Shann F et al. A randomized, controlled trial of once daily and multi-dose daily gentamicin in young Kenyan infants and children. Arch Dis Child 2004; 89:665-9.
12. Nestaas E, Bangstad H, Sandvik L, Wathne K. Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis. Arch Dis Child Fetal Neonatal Ed 2005;90:F294-300.
13. Darmstadt GL, Hossain MM, Jana AK, Saha SK, Choi Y, Sridhar S et al. Determination of extended-interval gentamicin dosing for neonatal patients in developing countries. Pediatr Infect Dis J 2007;26:501-7.
14. Darmstadt GL, Miller-Bell M, Batra M, Law P, Law K. Extended-interval dosing of gentamicin for treatment of neonatal sepsis in developed and developing countries. J Health Popul Nutr 2008;26:163-82.
15. Chambers HF. Antimicrobial agents: the aminoglycosides. In: Hardman JG, Limbird LE, Gilman AG, editors. Goodman and Gilman's The pharmacological basis of therapeutics. 10th ed. New York, NY: Mc- Graw Hill, 2001:1219-38.
16. McCraken GH, Jr., Jones LG. Gentamicin in the neonatal period. Am J Dis Child 1970;120:524-33.
17. Pons G, d'Athis P, Rey E, de Lauture D, Richard MO, Badoual J et al. Gentamicin monitoring in neonates. Ther Drug Monit 1988;80:421-7
18. Edward C, Low DC, Bissenden JG. Gentamicin dosage for the newborn. Lancet 1986;1:508-9.
19. World Health Organization. Management of the child with a serious infection or severe malnutrition: guidelines for care at the first-referral level in developing countries. Geneva: World Health Organization, 2000. 177 p. (WHO/FCH/CAH/00.1).
20. Skopnik H, Heimann G. Once-daily aminoglycoside dosing in full term neonates. Pediatr Infect Dis J 1995;14:71-2.
21. Skopnik H, Wallraf R, Nies B, Tröster K, Heimann G. Pharmacokinetics and antibacterial activity of daily gentamicin. Arch Dis Child 1992;67:57-61.
22. Gresores A, Hall DM, Kawato K, MCcartney K, Thureen PJ. A once daily gentamicin dosing regimen for neonates ≥34 weeks postconceptional age. Pediatr Res 1994;35:297A.
23. Grasso S, Meinardi RD, De Carneri I, Tamassai V. New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity. Antimicrob Agents Chemother 1987;13:570-6.
24. Leggett JE, Fantin B, Ebert S, Totsuka K, Vogelman B, Calame W et al. Comparative antibiotic dose-effect relation at several dosing intervals in murine pneumonitis and thigh-infection models. J Infect Dis 1989;159:281-92.
25. Mulhall A, Louvois J, Hurley R. Incidence of potentially toxic concentrations of gentamicin in the neonate. Arch Dis Child 1983;58:897-900
26. Hindmarsh KW, Nation RL, Williams GL, John E, French JN. Pharmacokinetics of gentamicin in very low birth weight preterm infants. Eur J Clin Pharmacol 1983;24:649-53.
27. Daikos GL, Jackson GG, Lolans VT, Livermore DM. Adaptive resistance to aminoglycoside antibiotics with implications for dosing. J Infect Dis 1990;162:414-20.
28. Heimann G. Renal toxicity of aminoglycosides in the neonatal period. Pediatr Pharmacol (NewYork) 1983;3:251-7.
29. Moore RD, Smith CR, Lietman PS. Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. J Infect Dis 1984;149:23-30.